Caligan Partners LP 13D/13G Filings for Anika Therapeutics, Inc. (ANIK)

Caligan Partners LP 13D and 13G filings for Anika Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-05-30
4:31 pm
Purchase		 2024-05-28 13D Anika Therapeutics, Inc.
ANIK		 Caligan Partners LP 1,435,993
9.700%		 12,500increase
(+0.88%)		 Filing
2024-03-06
7:30 pm
Purchase		 2024-03-04 13D Anika Therapeutics, Inc.
ANIK		 Caligan Partners LP 1,423,493
9.700%		 342,133increase
(+31.64%)		 Filing
2023-09-11
06:01 am
Purchase		 2023-09-08 13D Anika Therapeutics, Inc.
ANIK		 Caligan Partners LP 1,081,360
7.400%		 179,274increase
(+19.87%)		 Filing
2023-08-17
08:00 am
Purchase		 2023-08-09 13D Anika Therapeutics, Inc.
ANIK		 Caligan Partners LP 902,086
6.200%		 902,086increase
(New Position)		 Filing